Towards a complete resolution of the genetic architecture of disease

Trends in Genetics

Volumn 26, Issue 10, 2010, Pages 438-442

  Singleton, Andrew B ^a   Hardy, John ^b   Traynor, Bryan J ^a   Houlden, Henry ^b,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; RISK FACTOR;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RISK FACTORS;

EID: 77956788631     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2010.07.004     Document Type: Article

References (47)

1. Riordan J.R., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073.
2. Rommens J.M., et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989, 245:1059-1065.
3. Wallace D.C., et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
4. Kerem B., et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989, 245:1073-1080.
5. Hoffman E.P., et al. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
6. Koenig M., et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
7. Manolio T.A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
8. Goate A., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
9. Rogaev E.I., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995, 376:775-778.
10. Sherrington R., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
11. Paisan-Ruiz C., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
12. Zimprich A., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
13. Aharon-Peretz J., et al. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2004, 351:1972-1977.
14. Sidransky E., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 2009, 361:1651-1661.
15. Simon-Sanchez J., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
16. Harold D., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
17. Lambert J.C., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099.
18. Satake W., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
19. Gu Y., et al. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009, 458:1039-1042.
20. Katsanis N., et al. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 2001, 293:2256-2259.
21. den Dunnen, J.T. and Antonarakis, S.E. (2003) Mutation nomenclature. Curr. Protoc. Hum. Genet. UNIT 7.13.
22. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
23. Venter J.C., et al. The sequence of the human genome. Science 2001, 291:1304-1351.
24. Ng S.B., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461:272-276.
25. Ng S.B., et al. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42:30-35.
26. van de Leemput J., et al. Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet. 2007, 3:e108.
27. Gibbs J.R., Singleton A. Application of genome-wide single nucleotide polymorphism typing: simple association and beyond. PLoS Genet. 2006, 2:e150.
28. Knight M.A., et al. A duplication at chromosome 11q12.2-11q12.3 is associated with spinocerebellar ataxia type 20. Hum. Mol. Genet. 2008, 17:3847-3853.
29. Camargos S., et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol. 2008, 7:207-215.
30. Hardy J., Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 2009, 360:1759-1768.
31. Hindorff L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9362-9367.
32. Wang W.Y., et al. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 2005, 6:109-118.
33. McCarthy M.I., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 2008, 9:356-369.
34. Hunter D.J., Kraft P. Drinking from the fire hose - statistical issues in genomewide association studies. N. Engl. J. Med. 2007, 357:436-439.
35. Rose S.P. Commentary: heritability estimates - long past their sell-by date. Int. J. Epidemiol. 2006, 35:525-527.
36. Terwilliger J.D., Hiekkalinna T. An utter refutation of the 'fundamental theorem of the HapMap'. Eur. J. Hum. Genet. 2006, 14:426-437.
37. International Schizophrenia Consortium (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752.
38. Corder E.H., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
39. Klein R.J., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
40. Haines J.L., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
41. Edwards A.O., et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
42. Li M., et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat. Genet. 2006, 38:1049-1054.
43. Weiss L.A., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 2008, 358:667-675.
44. Barrett J.C., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40:955-962.
45. Traynor B.J. The era of genomic epidemiology. Neuroepidemiology 2009, 33:276-279.
46. Lander E.S. The new genomics: global views of biology. Science 1996, 274:536-539.
47. de Silva R., et al. Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy. Neurology 2003, 61:407-409.